Reuss Mark L 4
4 · General Motors Co · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
General Motors (GM) President Mark Reuss Exercises Options, Sells Shares
What Happened
Mark L. Reuss, President of General Motors, exercised vested stock options on February 17, 2026 and immediately sold shares in the open market. He exercised 82,489 options at $52.16 (cost $4,302,626) and 147,569 options at $35.49 (cost $5,237,224) — a total of 230,058 shares acquired for about $9.54M. On the same day he sold a total of 480,724 shares in multiple open-market transactions for aggregate proceeds of approximately $38.71M (sales reported at weighted average prices shown; see footnote on price ranges).
Key Details
- Transaction date: 2026-02-17; Form 4 filed 2026-02-18 (timely filing).
- Exercises (acquisitions): 82,489 @ $52.16 ($4,302,626) and 147,569 @ $35.49 ($5,237,224).
- Open-market sales: 82,489 @ $80.10 ($6,607,369); 147,569 @ $80.61 ($11,895,537); 249,567 @ $80.61 ($20,117,596); 1,099 @ $80.94 ($88,953). Total sales ≈ $38.71M.
- Filing shows two additional derivative "Disposed" line items reported at $0.00 for the exercised share amounts (see filing).
- Shares owned after the transactions are not specified in the data provided here.
- Footnotes: F1 — weighted average sale prices; sales occurred across prices $79.60–$81.36. F2/F3 — the exercised options were fully vested grants from Feb 18, 2021 and Feb 12, 2020.
Context
This appears to be an exercise of fully vested options followed by immediate open-market sales (a common pattern to cover exercise cost and taxes). The filing is routine reporting of insider activity; it is factual disclosure of transactions and does not indicate the insider's motives.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-17$52.16/sh+82,489$4,302,626→ 425,448 total - Sale
Common Stock
[F1]2026-02-17$80.10/sh−82,489$6,607,369→ 342,959 total - Exercise/Conversion
Common Stock
2026-02-17$35.49/sh+147,569$5,237,224→ 490,528 total - Sale
Common Stock
[F1]2026-02-17$80.61/sh−147,569$11,895,537→ 342,959 total - Sale
Common Stock
[F1]2026-02-17$80.61/sh−249,567$20,117,596→ 93,392 total - Sale
Common Stock
[F1]2026-02-17$80.94/sh−1,099$88,953→ 92,293 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F2]2026-02-17−82,489→ 0 totalExercise: $52.16Exp: 2031-02-18→ Common Stock (82,489 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F3]2026-02-17−147,569→ 0 totalExercise: $35.49Exp: 2030-02-12→ Common Stock (147,569 underlying)
Footnotes (3)
- [F1]The price in Column 4 is the weighted average sales price of the shares. The shares were sold in multiple transactions at prices from $79.60 to $81.36, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote.
- [F2]These stock options were granted on February 18, 2021 and are fully vested.
- [F3]These stock options were granted on February 12, 2020 and are fully vested.